Roswell Park Cancer Institute (RPCI), founded in 1898, is the nation’s first cancer research, treatment and education center, and is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. RPCI also is a member of the National Comprehensive Cancer Network. RPCI's 25-acre campus on the Buffalo Niagara Medical Campus includes approximately 1.5 million square feet of space. Approximately 60% of the campus has been renovated or newly built since 1998. The newest building on the RPCI campus, the 170,000 square feet Center for Genetics and Pharmacology, will open in Spring 2006.
RPCI’s mission is to conduct investigations regarding
cancer etiology, prevention, mortality and treatment. . The Institute’s
21 clinical, scientific and prevention departments conduct interdisciplinary
research through six major programs (Biophysical Therapies, Cancer
Prevention, Genetics, Prostate, Targeted Therapeutics, and Tumor Immunology) based
on five broad objectives that are fully integrated with Cancer Center
Support Grant functions:
- To develop new diagnostic, therapeutic and prevention approaches,
- To translate basic science advances into clinical applications and
capitalize on clinical observations to stimulate new laboratory research
contributing
to advances in cancer prevention, detection and treatment,
- To implement investigator-initiated clinical trials based on laboratory
discoveries and to engage fully in cooperative group trials,
- To develop diverse cancer prevention and population science research
programs and to sponsor innovative community outreach projects focusing
on high-risk
and medically-underserved populations, and
- To provide graduate programs in the life sciences and
professional medical education programs that train
the next generation of cancer
research scientists
and clinicians.
RPCI’s multidisciplinary centers include: Breast, Dermatology, Sarcoma, Melanoma, Thoracic, Gynecology, Head & Neck/Dental, Leukemia, Lymphoma, Multiple Myeloma, Neuro-Oncology & Pain Management, Pediatrics, Gastrointestinal and Urologic cancers. RPCI also offers specialized services and therapies not available elsewhere in the region, including: hematopoietic stem cell transplantation, photodynamic therapy; gamma knife radiosurgery; clinical genetics testing and counseling, a clinic for long-term survivors of childhood cancers, a regional center for maxillofacial prosthetics, the Buffalo-Niagara Prostate Cancer Consortium, a center for HIV-related malignancies, and a lymphedema clinic.
The RPCI Graduate Division of the University at Buffalo
offers doctoral programs in the areas of Cancer Pathology and Prevention,
Cellular and Molecular Biology, Immunology, Molecular and Cellular Biophysics
and Biochemistry and Molecular Pharmacology and Cancer Therapeutics and
an Interdisciplinary Master of Science Program. The Department of Educational
Affairs coordinates the training of approximately 250 clinical residents,
oncology fellows and visiting MDs each year, in addition to approximately
100 postdoctoral research fellows and 180 predoctoral graduate students.
|
